Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2Head & Neck 1Gastrointestinal 1

Conditions

Breast Neoplasms 2

Interventions

Paclitaxel 161Fulvestrant 155Trastuzumab 152pembrolizumab 144Letrozole 136Carboplatin 118pertuzumab 104Cyclophosphamide 102Capecitabine 102Specimen Handling 101Anastrozole 90palbociclib 85abemaciclib 81Magnetic Resonance Spectroscopy 81exemestane 76Docetaxel 76Tamoxifen 75ribociclib 73trastuzumab deruxtecan 69Radiotherapy 61Biopsy 59Surveys and Questionnaires 56Gemcitabine 52130-nm albumin-bound paclitaxel 52sacituzumab govitecan 50olaparib 50Standard of Care 49Blood Specimen Collection 49Taxes 47Doxorubicin 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Methylene Blue × Breast × 1 year × Clear all
NCT07040540 2026-04-30

Hemodynamic Effects of Intradermal Methylene Blue During Breast Surgery Under General Anesthesia

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Completed
220 enrolled
Breast

Breast Neoplasms

NCT00314405 2025-12-22

Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope

University Hospital, Strasbourg, France

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡